| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,058 |
2,893 |
$507K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,586 |
1,518 |
$326K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
193 |
188 |
$58K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
612 |
589 |
$55K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
27 |
26 |
$13K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14 |
14 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
42 |
40 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
353 |
336 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
659 |
628 |
$49.32 |
| 80053 |
Comprehensive metabolic panel |
1,059 |
992 |
$28.38 |
| 71046 |
Radiologic examination, chest; 2 views |
265 |
253 |
$27.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
359 |
341 |
$23.77 |
| 71045 |
Radiologic examination, chest; single view |
281 |
273 |
$17.67 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,070 |
1,021 |
$16.56 |
| 81003 |
|
696 |
674 |
$6.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
339 |
319 |
$4.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
657 |
628 |
$0.70 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
238 |
231 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
129 |
125 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
631 |
589 |
$0.00 |
| 73630 |
|
13 |
13 |
$0.00 |
| 81025 |
|
523 |
507 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
97 |
96 |
$0.00 |
| 87631 |
|
221 |
217 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
134 |
128 |
$0.00 |
| J3490 |
Unclassified drugs |
217 |
208 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
67 |
66 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
266 |
256 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
288 |
283 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,192 |
1,138 |
$0.00 |
| 82553 |
|
32 |
30 |
$0.00 |
| 84484 |
|
45 |
43 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14 |
13 |
$0.00 |